1. Home
  2. FAST vs NTRA Comparison

FAST vs NTRA Comparison

Compare FAST & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fastenal Company

FAST

Fastenal Company

N/A

Current Price

$55.41

Market Cap

58.2B

ML Signal

N/A

Logo Natera Inc.

NTRA

Natera Inc.

N/A

Current Price

$320.34

Market Cap

56.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FAST
NTRA
Founded
1967
2003
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
58.2B
56.7B
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
FAST
NTRA
Price
$55.41
$320.34
Analyst Decision
Hold
Strong Buy
Analyst Count
18
22
Target Price
$51.15
★ $410.02
AVG Volume (30 Days)
★ 7.1M
1.9M
Earning Date
10-14-2026
11-05-2026
Dividend Yield
★ 1.87%
N/A
EPS Growth
N/A
★ 0.65
EPS
★ 0.98
N/A
Revenue
★ $8,200,500,000.00
$210,939,000.00
Revenue This Year
$13.80
$30.65
Revenue Next Year
$9.70
$21.31
P/E Ratio
$56.70
★ N/A
Revenue Growth
★ 8.67
N/A
52 Week Low
$38.97
$181.00
52 Week High
$56.27
$437.41

Technical Indicators

Market Signals
Indicator
FAST
NTRA
Relative Strength Index (RSI) 68.52 32.93
Support Level $43.71 $308.33
Resistance Level N/A $334.60
Average True Range (ATR) 1.22 20.73
MACD 0.28 -9.77
Stochastic Oscillator 83.67 12.61

Price Performance

Historical Comparison
FAST
NTRA

About FAST Fastenal Company

Fastenal began as an industrial retailer, expanding its product portfolio from nuts and bolts to cutting tools, safety equipment, and janitorial supplies. It transitioned into a distributor by building out a dense network of branches close to its business customers. Once a customer becomes large enough, Fastenal installs vending machines and its own personnel on-site. Today, these on-site locations exceed Fastenal's branch count and remain the firm's main focus for expansion. Fastenal acts as a one-stop outsourcing partner for its industrial customers, offering value-added services along with a wide breadth of maintenance, repair, and operations supplies.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: